Please login to the form below

Not currently logged in
Email:
Password:

type 2 diabetes

This page shows the latest type 2 diabetes news and features for those working in and with pharma, biotech and healthcare.

World Diabetes Day 2019

World Diabetes Day 2019

A new international survey from Merck has demonstrated a significant lack of knowledge about the risk factors associated with type 2 diabetes. . ... According to the International Diabetes Federation, the vast majority of these cases are type 2 diabetes,

Latest news

More from news
Approximately 33 fully matching, plus 440 partially matching documents found.

Latest Intelligence

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    This is the first large real-world evidence study of its kind, evaluating the risk of hospitalisation for heart failure and death from any cause in patients with type 2 diabetes ... The drug has so far gained approval for use in patients with germline

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    to reverse type 2 diabetes in patients. ... The region is now adopting population health models for musculoskeletal (MSK) respiratory disease, diabetes and cardiovascular disease.

  • Deal Watch October 2018

    Novartis. Deal Type. Deal with. Details. Value. Acquisition. Endocyte. Portfolio of products and technology for. ... Suliqua &Lyxumia/ Adlyxin for Type 2 diabetes. Purchase of. royalty rights.

  • Quality in Care Diabetes 2018: the best in innovative diabetes care Quality in Care Diabetes 2018: the best in innovative diabetes care

    Now in its eighth year, QiC Diabetes rewards initiatives undertaken in the UK and Ireland to improve outcomes and quality of life for people living with diabetes – spanning people with type ... 1 and type 2 diabetes, and adults’ and children’s

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    AstraZeneca launched five significant new medicines in 2017: immunotherapy Iminzi, Calquence for mantle cell lymphoma, Qtern in type 2 diabetes, Bevespi Aerosphere in COPD and Fasenra for severe asthma. ... AstraZeneca’s global HQ and Research

More from intelligence
Approximately 5 fully matching, plus 39 partially matching documents found.

Latest appointments

  • Roche’s Torsten Hoffmann to join Zealand Pharma Roche’s Torsten Hoffmann to join Zealand Pharma

    In his new role at Zealand, Dr Hoffmann joins a more compact company focused on the discovery of drugs in cardio-metabolic diseases, diabetes and obesity. ... Its lead product is the GLP-1 agonist lixisenatide, which is licensed to Sanofi who markets it

  • bmore creative hires Kush Rach as new business director bmore creative hires Kush Rach as new business director

    He was a key account manager at the pharma company, where he worked in the diabetes therapeutic area, and was involved in the UK launch of Galvus (vildagliptin) for type 2 ... diabetes. Ben Blackmore, bmore creative's MD, told The Directory: "We are

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...

Infographics